Alexandra Glucksmann - Net Worth and Insider Trading
Alexandra Glucksmann Net Worth
The estimated net worth of Alexandra Glucksmann is at least $367,499 dollars as of 2024-11-10. Alexandra Glucksmann is the COO of Editas Medicine Inc and owns about 117,788 shares of Editas Medicine Inc (EDIT) stock worth over $367,499. Details can be seen in Alexandra Glucksmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexandra Glucksmann has not made any transactions after 2017-03-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alexandra Glucksmann
Alexandra Glucksmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexandra Glucksmann owns 2 companies in total, including Regenxbio Inc (RGNX) , and Editas Medicine Inc (EDIT) .
Click here to see the complete history of Alexandra Glucksmann’s form 4 insider trades.
Insider Ownership Summary of Alexandra Glucksmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RGNX | Regenxbio Inc | 2018-05-25 | director |
| EDIT | Editas Medicine Inc | 2017-03-15 | Chief Operating Officer |
Alexandra Glucksmann Latest Holdings Summary
Alexandra Glucksmann currently owns a total of 1 stock. Alexandra Glucksmann owns 117,788 shares of Editas Medicine Inc (EDIT) as of March 15, 2017, with a value of $367,499.
Latest Holdings of Alexandra Glucksmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EDIT | Editas Medicine Inc | 2017-03-15 | 117,788 | 3.12 | 367,499 |
Holding Weightings of Alexandra Glucksmann
Alexandra Glucksmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexandra Glucksmann has made a total of 0 transactions in Editas Medicine Inc (EDIT) over the past 5 years. The most-recent trade in Editas Medicine Inc is the sale of 1,000 shares on March 15, 2017, which brought Alexandra Glucksmann around $26,410.
Insider Trading History of Alexandra Glucksmann
- 1
Alexandra Glucksmann Trading Performance
Alexandra Glucksmann Ownership Network
Ownership Network List of Alexandra Glucksmann
Ownership Network Relation of Alexandra Glucksmann
Alexandra Glucksmann Owned Company Details
What does Regenxbio Inc do?
Who are the key executives at Regenxbio Inc?
Alexandra Glucksmann is the director of Regenxbio Inc. Other key executives at Regenxbio Inc include SVP of Technical Operations Curran Simpson , director & See Remarks Kenneth T. Mills , and Chief Medical Officer Steve Pakola .
Regenxbio Inc (RGNX) Insider Trades Summary
Over the past 18 months, Alexandra Glucksmann made no insider transaction in Regenxbio Inc (RGNX). Other recent insider transactions involving Regenxbio Inc (RGNX) include a net sale of 180,000 shares made by Kenneth T. Mills , a net sale of 51,100 shares made by Argeris N Karabelas , and a net sale of 9,748 shares made by Curran Simpson .
In summary, during the past 3 months, insiders sold 20,000 shares of Regenxbio Inc (RGNX) in total and bought 0 shares, with a net sale of 20,000 shares. During the past 18 months, 253,726 shares of Regenxbio Inc (RGNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 253,726 shares.
Regenxbio Inc (RGNX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Regenxbio Inc Insider Transactions
Alexandra Glucksmann Mailing Address
Above is the net worth, insider trading, and ownership report for Alexandra Glucksmann. You might contact Alexandra Glucksmann via mailing address: C/o Regenxbio Inc., 9804 Medical Center Drive, Rockville Md 20850.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
